Evolving concepts in cell therapy of liver disease and current clinical perspectives

Maurizio Muraca

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The clinical use of cells for the treatment of liver disease is not a mere hypothesis. Indeed, it has been known for more than 30 years that, following intraportal infusion, exogenous hepatocytes isolated from a donor liver engraft into the recipient hepatic parenchyma and express metabolic activity. These experimental results encouraged pilot clinical trials using hepatocytes transplantation to treat a variety of liver diseases. More recently, the discovery of liver stem/progenitor cells further fueled the interest in the field. However, it appears that successful liver cell therapy will require better understanding of the mechanisms governing liver regeneration and of their implication in cell transplantation. This review summarizes some recent advances in the field in a bench-to-bedside perspective.

Original languageEnglish
Pages (from-to)180-187
Number of pages8
JournalDigestive and Liver Disease
Volume43
Issue number3
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Cell- and Tissue-Based Therapy
Liver Diseases
Liver
Hepatocytes
Stem Cells
Liver Regeneration
Cell Transplantation
Transplantation
Clinical Trials
Therapeutics

Keywords

  • Liver cell therapy
  • Liver stem cells

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Evolving concepts in cell therapy of liver disease and current clinical perspectives. / Muraca, Maurizio.

In: Digestive and Liver Disease, Vol. 43, No. 3, 03.2011, p. 180-187.

Research output: Contribution to journalArticle

@article{e3bc985749fa4785abd9cccd6d3d2112,
title = "Evolving concepts in cell therapy of liver disease and current clinical perspectives",
abstract = "The clinical use of cells for the treatment of liver disease is not a mere hypothesis. Indeed, it has been known for more than 30 years that, following intraportal infusion, exogenous hepatocytes isolated from a donor liver engraft into the recipient hepatic parenchyma and express metabolic activity. These experimental results encouraged pilot clinical trials using hepatocytes transplantation to treat a variety of liver diseases. More recently, the discovery of liver stem/progenitor cells further fueled the interest in the field. However, it appears that successful liver cell therapy will require better understanding of the mechanisms governing liver regeneration and of their implication in cell transplantation. This review summarizes some recent advances in the field in a bench-to-bedside perspective.",
keywords = "Liver cell therapy, Liver stem cells",
author = "Maurizio Muraca",
year = "2011",
month = "3",
doi = "10.1016/j.dld.2010.08.007",
language = "English",
volume = "43",
pages = "180--187",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "3",

}

TY - JOUR

T1 - Evolving concepts in cell therapy of liver disease and current clinical perspectives

AU - Muraca, Maurizio

PY - 2011/3

Y1 - 2011/3

N2 - The clinical use of cells for the treatment of liver disease is not a mere hypothesis. Indeed, it has been known for more than 30 years that, following intraportal infusion, exogenous hepatocytes isolated from a donor liver engraft into the recipient hepatic parenchyma and express metabolic activity. These experimental results encouraged pilot clinical trials using hepatocytes transplantation to treat a variety of liver diseases. More recently, the discovery of liver stem/progenitor cells further fueled the interest in the field. However, it appears that successful liver cell therapy will require better understanding of the mechanisms governing liver regeneration and of their implication in cell transplantation. This review summarizes some recent advances in the field in a bench-to-bedside perspective.

AB - The clinical use of cells for the treatment of liver disease is not a mere hypothesis. Indeed, it has been known for more than 30 years that, following intraportal infusion, exogenous hepatocytes isolated from a donor liver engraft into the recipient hepatic parenchyma and express metabolic activity. These experimental results encouraged pilot clinical trials using hepatocytes transplantation to treat a variety of liver diseases. More recently, the discovery of liver stem/progenitor cells further fueled the interest in the field. However, it appears that successful liver cell therapy will require better understanding of the mechanisms governing liver regeneration and of their implication in cell transplantation. This review summarizes some recent advances in the field in a bench-to-bedside perspective.

KW - Liver cell therapy

KW - Liver stem cells

UR - http://www.scopus.com/inward/record.url?scp=79551482651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551482651&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2010.08.007

DO - 10.1016/j.dld.2010.08.007

M3 - Article

VL - 43

SP - 180

EP - 187

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 3

ER -